White matter hypoperfusion and damage in dementia: Post-mortem assessment

Brain Pathology

Volumn 25, Issue 1, 2015, Pages 99-107

  Love, Seth ^a   Miners, J Scott ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Alzheimer's disease; cerebrovascular disease; ischemia; molecular markers; vascular dementia; white matter

Indexed keywords

ANIMAL; BRAIN; BRAIN CIRCULATION; DEMENTIA; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION; WHITE MATTER;

ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; DEMENTIA; HUMANS; WHITE MATTER;

EID: 84923359693     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12223     Document Type: Conference Paper

References (122)

1. Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Bruck W, et al (2003) Preferential loss of myelin-Associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 62: 25-33.
2. Acker T, Acker H, (2004) Cellular oxygen sensing need in CNS function: physiological and pathological implications. J Exp Biol 207: 3171-3188.
3. Alexander AL, Lee JE, Lazar M, Field AS, (2007) Diffusion tensor imaging of the brain. Neurotherapeutics 4: 316-329.
4. Ashby EL, Love S, Kehoe PG, (2012) Assessment of activation of the plasma kallikrein-kinin system in frontal and temporal cortex in Alzheimer's disease and vascular dementia. Neurobiol Aging 33: 1345-1355.
5. Ballard C, O'Brien J, Barber B, Scheltens P, Shaw F, McKeith I, Kenny RA, (2000) Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementia. Ann N Y Acad Sci 903: 442-445.
6. Ballard C, Shaw F, McKeith I, Kenny R, (1998) High prevalence of neurovascular instability in neurodegenerative dementias. Neurology 51: 1760-1762.
7. Barker R, Ashby EL, Wellington D, Barrow VM, Palmer JC, Kehoe PG, et al (2014) Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain 137: 1524-1532.
8. Barker R, Wellington D, Esiri MM, Love S, (2013) Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. J Cereb Blood Flow Metab 33: 1050-1057.
9. Beach TG, Wilson JR, Sue LI, Newell A, Poston M, Cisneros R, et al (2007) Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol 113: 13-21.
10. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV, (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68: 409-427.
11. Bellucci A, Collo G, Sarnico I, Battistin L, Missale C, Spano P, (2008) α-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation. J Neurochem 106: 560-577.
12. Borroni B, Perani D, Broli M, Colciaghi F, Garibotto V, Paghera B, et al (2005) Pre-clinical diagnosis of Alzheimer disease combining platelet amyloid precursor protein ratio and rCBF spect analysis. J Neurol 252: 1359-1362.
13. Bozzali M, Falini A, Franceschi M, Cercignani M, Zuffi M, Scotti G, et al (2002) White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 72: 742-746.
14. Brun A, Englund E, (1986) Brain changes in dementia of Alzheimer's type relevant to new imaging diagnostic methods. Prog Neuropsychopharmacol Biol Psychiatry 10: 297-308.
15. Brun A, Englund E, (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19: 253-262.
16. Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ, (2012) Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab 32: 425-436.
17. Capizzano AA, Acion L, Bekinschtein T, Furman M, Gomila H, Martinez A, et al (2004) White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75: 822-827.
18. Carson JA, Turner AJ, (2002) β-Amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J Neurochem 81: 1-8.
19. Chalmers K, Wilcock G, Love S, (2005) Contributors to white matter damage in the frontal lobe in Alzheimer's disease. Neuropathol Appl Neurobiol 31: 623-631.
20. Chau KY, Ching HL, Schapira AH, Cooper JM, (2009) Relationship between α synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis. J Neurochem 110: 1005-1013.
21. Chen B, Cheng Q, Yang K, Lyden PD, (2010) Thrombin mediates severe neurovascular injury during ischemia. Stroke 41: 2348-2352.
22. Chen L, Feany MB, (2005) α-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8: 657-663.
23. Chen ZL, Strickland S, (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91: 917-925.
24. Choi SA, Evidente VG, Caviness JN, (2010) Comparing cerebral white matter lesion burdens between Parkinson's disease with and without dementia. J Mov Disord 3: 6-10.
25. Choi SA, Evidente VG, Caviness JN, Shill HA, Sabbagh MN, Connor DJ, et al (2010) Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia? Acta Neuropathol 119: 147-149.
26. Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, et al (2006) Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol 60: 677-687.
27. Chui HC, Zheng L, Reed BR, Vinters HV, Mack WJ, (2012) Vascular risk factors and Alzheimer's disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res Ther 4: 1.
28. Eckman EA, Adams SK, Troendle FJ, Stodola BA, Kahn MA, Fauq AH, et al (2006) Regulation of steady-state β-Amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. J Biol Chem 281: 30471-30478.
29. Eckman EA, Reed DK, Eckman CB, (2001) Degradation of the Alzheimer's amyloid β peptide by endothelin-converting enzyme. J Biol Chem 276: 24540-24548.
30. Eckman EA, Watson M, Marlow L, Sambamurti K, Eckman CB, (2003) Alzheimer's disease β-Amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem 278: 2081-2084.
31. Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM, (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55: 250-256.
32. Englund E, Brun A, (1990) White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments. Histopathology 16: 433-439.
33. Englund E, Brun A, Alling C, (1988) White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain 111: 1425-1439.
34. Esiri MM, Joachim C, Sloan C, Christie S, Agacinski G, Bridges LR, et al (2014) Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). Alzheimer Dis Assoc Disord 28: 30-35.
35. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD, (1999) Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354: 919-920.
36. Esiri MM, Wilcock GK, Morris JH, (1997) Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 63: 749-753.
37. Fernando MS, Ince PG, Function MRCC, Ageing Neuropathology Study Group (2004) Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 226: 13-17.
38. Fernando MS, O'Brien JT, Perry RH, English P, Forster G, McMeekin W, et al (2004) Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol 30: 385-395.
39. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, et al (2006) White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 37: 1391-1398.
40. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT, (2003) Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 20: 1309-1319.
41. Fisk L, Nalivaeva NN, Boyle JP, Peers CS, Turner AJ, (2007) Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem Res 32: 1741-1748.
42. Gold BT, Jiang Y, Powell DK, Smith CD, (2012) Multimodal imaging evidence for axonal and myelin deterioration in amnestic mild cognitive impairment. J Alzheimers Dis 31 (Suppl. 3): S19-S31.
43. Gold BT, Johnson NF, Powell DK, Smith CD, (2012) White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions. Biochim Biophys Acta 1822: 416-422.
44. Guglielmotto M, Aragno M, Autelli R, Giliberto L, Novo E, Colombatto S, et al (2009) The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α. J Neurochem 108: 1045-1056.
45. Hattori T, Orimo S, Aoki S, Ito K, Abe O, Amano A, et al (2012) Cognitive status correlates with white matter alteration in Parkinson's disease. Hum Brain Mapp 33: 727-739.
46. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al (1997) Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 349: 151-154.
47. Honig LS, Kukull W, Mayeux R, (2005) Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology 64: 494-500.
48. Imran MB, Kawashima R, Awata S, Sato K, Kinomura S, Ono S, et al (1999) Tc-99m HMPAO SPECT in the evaluation of Alzheimer's disease: correlation between neuropsychiatric evaluation and CBF images. J Neurol Neurosurg Psychiatry 66: 228-232.
49. Ishimaru H, Ueda K, Takahashi A, Maruyama Y, (1998) Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus. Brain Res 788: 311-314.
50. Ito R, Mori S, Melhem ER, (2002) Diffusion tensor brain imaging and tractography. Neuroimaging Clin N Am 12: 1-19.
51. Jacobs HI, Visser PJ, Van Boxtel MP, Frisoni GB, Tsolaki M, Papapostolou P, et al (2012) Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging 33: e1-e8.
52. Jellinger KA, (2008) Morphologic diagnosis of "vascular dementia"-A critical update. J Neurol Sci 270: 1-12.
53. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, et al (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234: 851-859.
54. Kaelin WG Jr, Ratcliffe PJ, (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30: 393-402.
55. Kalaria RN, Perry RH, O'Brien J, Jaros E, (2012) Atheromatous disease in small intracerebral vessels, microinfarcts and dementia. Neuropathol Appl Neurobiol 38: 505-508.
56. Kalback W, Esh C, Castano EM, Rahman A, Kokjohn T, Luehrs DC, et al (2004) Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res 26: 525-539.
57. Kaneko K, Kuwabara Y, Sasaki M, Ogomori K, Ichimiya A, Koga H, et al (2004) Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT. Clin Nucl Med 29: 362-366.
58. Kenny RA, Kalaria R, Ballard C, (2002) Neurocardiovascular instability in cognitive impairment and dementia. Ann N Y Acad Sci 977: 183-195.
59. Kenny RA, Shaw FE, O'Brien JT, Scheltens PH, Kalaria R, Ballard C, (2004) Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions. J Neurol Neurosurg Psychiatry 75: 966-971.
60. Lee SJ, Kim JS, Yoo JY, Song IU, Kim BS, Jung SL, et al (2010) Influence of white matter hyperintensities on the cognition of patients with Parkinson disease. Alzheimer Dis Assoc Disord 24: 227-233.
61. Li L, Zhang X, Yang D, Luo G, Chen S, Le W, (2009) Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP. Neurobiol Aging 30: 1091-1098.
62. Love S, Miners S, Palmer J, Chalmers K, Kehoe P, (2009) Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. Front Biosci (Landmark Ed) 14: 4778-4792.
63. McAleese KE, Firbank M, Hunter D, Sun L, Hall R, Neal JW, et al (2013) Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter. Neuropathol Appl Neurobiol 39: 485-497.
64. Melhem ER, Mori S, Mukundan G, Kraut MA, Pomper MG, van Zijl PC, (2002) Diffusion tensor MR imaging of the brain and white matter tractography. AJR Am J Roentgenol 178: 3-16.
65. Mhatre M, Nguyen A, Kashani S, Pham T, Adesina A, Grammas P, (2004) Thrombin, a mediator of neurotoxicity and memory impairment. Neurobiol Aging 25: 783-793.
66. Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S, (2008) Aβ-degrading enzymes in Alzheimer's disease. Brain Pathol 18: 240-252.
67. Miners JS, Barua N, Kehoe PG, Gill S, Love S, (2011) Aβ-degrading enzymes: potential for treatment of Alzheimer disease. J Neuropathol Exp Neurol 70: 944-959.
68. Miners S, Ashby E, Baig S, Harrison R, Tayler H, Speedy E, et al (2009) Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res 1: 163-177.
69. Miners S, Moulding H, de Silva R, Love S, (2014) Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies. Brain Pathol 24: 334-343.
70. Nanduri J, Yuan G, Kumar GK, Semenza GL, Prabhakar NR, (2008) Transcriptional responses to intermittent hypoxia. Respir Physiol Neurobiol 164: 277-281.
71. Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA, Iadecola C, (2002) Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 283: H315-H323.
72. Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C, (2002) Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis 9: 61-68.
73. Niwa K, Porter VA, Kazama K, Cornfield D, Carlson GA, Iadecola C, (2001) Aβ-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol 281: H2417-H2424.
74. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A, (1997) Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 28: 316-321.
75. Palmer JC, Baig S, Kehoe PG, Love S, (2009) Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Aβ. Am J Pathol 175: 262-270.
76. Palmer JC, Barker R, Kehoe PG, Love S, (2012) Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β. J Alzheimers Dis 29: 853-861.
77. Palmer JC, Tayler HM, Love S, (2013) Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's disease. J Alzheimers Dis 36: 577-587.
78. Patel NS, Mathura VS, Bachmeier C, Beaulieu-Abdelahad D, Laporte V, Weeks O, et al (2009) Alzheimer's β-Amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2. J Neurochem 112: 66-76.
79. Patel NS, Quadros A, Brem S, Wotoczek-Obadia M, Mathura VS, Laporte V, et al (2008) Potent anti-Angiogenic motifs within the Alzheimer β-Amyloid peptide. Amyloid 15: 5-19.
80. Perea RD, Rada RC, Wilson J, Vidoni ED, Morris JK, Lyons KE, et al (2013) A comparative white matter study with Parkinson's disease, Parkinson's disease with dementia and Alzheimer's disease. J Alzheimers Dis Parkinsonism 3: 123.
81. Pievani M, Agosta F, Pagani E, Canu E, Sala S, Absinta M, et al (2010) Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp 31: 1862-1875.
82. Powell FL, Fu Z, (2008) HIF-1 and ventilatory acclimatization to chronic hypoxia. Respir Physiol Neurobiol 164: 282-287.
83. Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, et al (2014) Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: a multimodal imaging investigation. Neuroimage Clin 4: 604-614.
84. Ravaglia G, Forti P, Maioli F, Chiappelli M, Montesi F, Tumini E, et al (2007) Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging. Neurobiol Aging 28: 1810-1820.
85. Richardson K, Stephan BC, Ince PG, Brayne C, Matthews FE, Esiri MM, (2012) The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Curr Alzheimer Res 9: 687-696.
86. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, et al (2003) Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 23: 2055-2062.
87. Roher AE, Esh C, Rahman A, Kokjohn TA, Beach TG, (2004) Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 35: 2623-2627.
88. Roher AE, Tyas SL, Maarouf CL, Daugs ID, Kokjohn TA, Emmerling MR, et al (2011) Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia. Alzheimers Dement 7: 436-444.
89. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM, (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57: 789-794.
90. Scheltens P, Barkhof F, Valk J, Algra PR, van der Hoop RG, Nauta J, Wolters EC, (1992) White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain 115 (Pt 3): 735-748.
91. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA, (2004) Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology 62: 1148-1155.
92. Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, et al (2005) Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128: 500-515.
93. Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP, (2011) A meta-Analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 32: e5-e18.
94. Shi J, Yang SH, Stubley L, Day AL, Simpkins JW, (2000) Hypoperfusion induces overexpression of beta-Amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res 853: 1-4.
95. Shinall H, Song ES, Hersh LB, (2005) Susceptibility of amyloid β peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral. Biochemistry 44: 15345-15350.
96. Smallwood A, Oulhaj A, Joachim C, Christie S, Sloan C, Smith AD, Esiri M, (2012) Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol Appl Neurobiol 38: 337-343.
97. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D, (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid β peptide. Neuron 39: 43-56.
98. Strozyk D, Dickson DW, Lipton RB, Katz M, Derby CA, Lee S, et al (2010) Contribution of vascular pathology to the clinical expression of dementia. Neurobiol Aging 31: 1710-1720.
99. Sun Y, Jin K, Mao XO, Zhu Y, Greenberg DA, (2001) Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury. Proc Natl Acad Sci U S A 98: 15306-15311.
100. Tanimukai H, Imaizumi K, Kudo T, Katayama T, Tsuda M, Takagi T, et al (1998) Alzheimer-Associated presenilin-1 gene is induced in gerbil hippocampus after transient ischemia. Brain Res Mol Brain Res 54: 212-218.
101. Teipel SJ, Meindl T, Wagner M, Stieltjes B, Reuter S, Hauenstein KH, et al (2010) Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J Alzheimers Dis 22: 507-522.
102. Thomas TL, Kehoe PG, Love S, (2013) Elevated VEGF in the cerebral cortex in Alzheimer's disease is not attributable to arteriosclerotic small vessel disease or cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 39: 45.
103. Tschope C, Schultheiss HP, Walther T, (2002) Multiple interactions between the renin-Angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade. J Cardiovasc Pharmacol 39: 478-487.
104. Turner AJ, Isaac RE, Coates D, (2001) The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays 23: 261-269.
105. Turner AJ, Tanzawa K, (1997) Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 11: 355-364.
106. Unal-Cevik I, Gursoy-Ozdemir Y, Yemisci M, Lule S, Gurer G, Can A, et al (2011) α-Synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]α-synuclein transgenic mouse. J Cereb Blood Flow Metab 31: 913-923.
107. Wang DS, Iwata N, Hama E, Saido TC, Dickson DW, (2003) Oxidized neprilysin in aging and Alzheimer's disease brains. Biochem Biophys Res Commun 310: 236-241.
108. Wang R, Wang S, Malter JS, Wang DS, (2009) Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells. J Neurochem 108: 1072-1082.
109. Wang Y, West JD, Flashman LA, Wishart HA, Santulli RB, Rabin LA, et al (2012) Selective changes in white matter integrity in MCI and older adults with cognitive complaints. Biochim Biophys Acta 1822: 423-430.
110. Wardlaw JM, Doubal FN, Valdes-Hernandez M, Wang X, Chappell FM, Shuler K, et al (2013) Blood-brain barrier permeability and long-term clinical and imaging outcomes in cerebral small vessel disease. Stroke 44: 525-527.
111. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12: 822-838.
112. Wen Y, Onyewuchi O, Yang S, Liu R, Simpkins JW, (2004) Increased β-secretase activity and expression in rats following transient cerebral ischemia. Brain Res 1009: 1-8.
113. Wen Y, Yang S, Liu R, Brun-Zinkernagel AM, Koulen P, Simpkins JW, (2004) Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J Biol Chem 279: 22684-22692.
114. Wen Y, Yang S, Liu R, Simpkins JW, (2004) Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res 1022: 30-38.
115. Yang S-P, Bae D-G, Kang HJ, Gwag BJ, Gho YS, Chae C-B, (2004) Co-Accumulation of vascular endothelial growth factor with β-Amyloid in the brain of patients with Alzheimer's disease. Neurobiol Aging 25: 283-290.
116. Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB, et al (2012) Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain 135: 3749-3756.
117. Yoon DK, Hwang IK, Yoo KY, Lee YB, Lee JJ, Kim JH, et al (2006) Comparison of α-synuclein immunoreactivity and protein levels in ischemic hippocampal CA1 region between adult and aged gerbils and correlation with Cu,Zn-superoxide dismutase. Neurosci Res 55: 434-441.
118. Yu S, Liu XM, Li YH, Lu GW, Chen B, (2004) Effect of repeated acute hypoxic treatment on the expression of α-synuclein in the mouse brain cortex [Chinese]. Sheng Li Xue Bao 56: 263-268.
119. Yuan J, Wen G, Li Y, Liu C, (2013) The occurrence of cerebrovascular atherosclerosis in Alzheimer's disease patients. Clin Interv Aging 8: 581-584.
120. Zetterberg H, Mortberg E, Song L, Chang L, Provuncher GK, Patel PP, et al (2011) Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans. PLoS ONE 6: e28263.
121. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao FF, et al (2007) Hypoxia-inducible factor 1α (HIF-1α)-mediated hypoxia increases BACE1 expression and β-Amyloid generation. J Biol Chem 282: 10873-10880.
122. Zhiyou C, Yong Y, Shanquan S, Jun Z, Liangguo H, Ling Y, Jieying L, (2009) Upregulation of BACE1 and β-Amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease. Neurochem Res 34: 1226-1235.